BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Auven Therapeutics (previously known as Celtic Therapeutics Management L.L.L.P.)  



New York City  New York    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






 Company News
Celtic Therapeutics Rebrands as Auven Therapeutics (previously known as Celtic Therapeutics Management L.L.L.P.) 3/11/2013 10:57:34 AM    More...
Celtic Therapeutics Announces the Appointment of New Partner 10/29/2012 6:58:58 AM    More...
Celtic Therapeutics Pledges $50 Million to Establish ADC Therapeutics, New Company Will Develop Antibody-Drug Conjugates 3/26/2012 7:29:25 AM    More...
Resolvyx Pharmaceuticals, Inc. and Celtic Therapeutics Enter Final Agreement in Ophthalmology 1/10/2011 6:23:25 AM    More...
Resolvyx Pharmaceuticals, Inc. and Celtic Therapeutics Ink Dry Eye Deal 10/26/2010 7:58:47 AM    More...
Celtic Therapeutics and Spirogen Limited Release: Commencement of a Phase II Clinical Trial of SG2000 in Ovarian Cancer 9/15/2010 12:04:50 PM    More...
BELLUS Health and Celtic Therapeutics Enter Agreement Worth $20 Million for Drug candidate KIACTA(TM) 4/30/2010 1:08:14 PM    More...
Geller Biopharm Successfully Advises BELLUS Health in Its KIACTA(TM) Transaction With Celtic Therapeutics 4/30/2010 10:38:16 AM    More...
PPD, Inc. (PPDI) to Invest $100 Million in Celtic Therapeutics 10/28/2009 7:31:27 AM    More...
Celtic Therapeutics Announces First Closing and Two Senior Appointments 12/22/2008 8:36:07 AM    More...
12

//-->